The fact that we were unable to find a significant association between mammaglobin-A expression and patient outcome in 1139 cases of invasive breast cancer of homogeneous histologic subtype (all NST) might suggest that mammaglobin-A expression is not a critical prognostic feature in breast cancer. Here, SCGB2A2 is linked to invasive breast carcinoma.